Order Article Reprints

Foote RL, Harmsen WS, Amundson AC, Carr AB, Gamez ME, Garces YI, Lester SC, Ma DJ, McGee LA, Moore EJ, et al. Mean Oral Cavity Organ-at-Risk Dose Predicts Opioid Use and Hospitalization during Radiotherapy for Patients with Head and Neck Tumors. Cancers. 2024; 16(2):349. https://doi.org/10.3390/cancers16020349

Foote, Robert L., W. Scott Harmsen, Adam C. Amundson, Alan B. Carr, Mauricio E. Gamez, Yolanda I. Garces, Scott C. Lester, Daniel J. Ma, Lisa A. McGee, Eric J. Moore, and et al. 2024. "Mean Oral Cavity Organ-at-Risk Dose Predicts Opioid Use and Hospitalization during Radiotherapy for Patients with Head and Neck Tumors" Cancers 16, no. 2: 349. https://doi.org/10.3390/cancers16020349

Foote, R. L., Harmsen, W. S., Amundson, A. C., Carr, A. B., Gamez, M. E., Garces, Y. I., Lester, S. C., Ma, D. J., McGee, L. A., Moore, E. J., Neben Wittich, M. A., Patel, S. H., Routman, D. M., Rwigema, J.-C. M., Van Abel, K. M., Yin, L. X., Muller, O. M., & Shiraishi, S. (2024). Mean Oral Cavity Organ-at-Risk Dose Predicts Opioid Use and Hospitalization during Radiotherapy for Patients with Head and Neck Tumors. Cancers, 16(2), 349. https://doi.org/10.3390/cancers16020349